Skip to content
Site Tools
Narrow screen resolution Wide screen resolution Auto adjust screen size Increase font size Decrease font size Default font size default color blue color green color
 XPert Fertility Care of California has been established since 1996. Overcoming infertility could be challenging at times, but with expertise and genuine care, Dr. Ho's has successfully helped thousands of couples to fulfill their dreams of having a family...
 
You are here: Home arrow PGD - Sex Selection arrow IVF XPERT (XPert Fertility Care arrow     
ALL |0-9 |A |B |C |D |E |F |G |H |I |J |K |L |M |N |O |P |Q |R |S |T |U |V |W |X |Y |Z

IVF XPERT (XPert Fertility Care arrow

Preimplantation Genetic Diagnosis Print E-mail
Tuesday, 20 March 2007

At XPert Fertility Care, our goal is to provide the most advanced reproductive healthcare that allows us to remain at the forefront of Reproductive Medicine. We are proud to offer the latest and most unique reproductive technologies, including pre-implantation genetic diagnosis (PGD) and chromosomal analysis (FISH). Pre-implantation Genetic Diagnosis is offered to couples at risk of having a genetically abnormal child and as an alternative to prenatal diagnosis. Although, PGD has been available since 1990, there has been a slow but steady increase in the number of programs (now exceeding 40 worldwide) offering this highly advanced and valuable reproductive medical technology.

This procedure is used in conjunction with In-Vitro Fertilization by performing an embryo biopsy usually of a single blastomere cell at the 6 to 8 cell stage of development. PGD combines the expertise of assisted reproduction and molecular genetics. Today, the number of genetic diseases detectable by PGD has increased significantly to include most common autosomal dominant and recessive diseases (e.g. cystic fibrosis, thalassemias, sickle cell anemia, and Duchenne's muscular dystrophy) as well as the diagnosis of chromosomal translocations for patients with recurrent pregnancy loss.

Additionally, chromosomal analysis during the preimplantation stage by using Fluorescent In-situ Hybridization (FISH) has the potential to reduce the number of trisomic and monosomic pregnancies (e.g. Down's syndrome), increase the pregnancy rates in women over age 40, and reduce embryo loss during pregnancy.

In a recent review of PGD around the world, the most common reasons for referral for the procedure was a suspected gene for cystic fibrosis, Duchenne's or Becker's muscular dystrophy, myotonic dystrophy, hemophilia, or Huntington's disease. In these cases, most patients had affected children and decided to pursue PGD prior to attempting another pregnancy. Out of 70 cases, only a single (1.4%) misreported diagnosis occurred that was diagnosed by amniocentesis.

Read more about pgd


Last Updated ( Thursday, 12 April 2007 )
 
Related articles

 

Main

Home

Dr.'s Blog

Categories